{"disease":{"id":"gynecological-tumors","name":"gynecological tumors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06159907","title":"Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Gynecological Tumors.","phase":"","overall_status":"UNKNOWN","enrollment_count":380,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT07259681","title":"Gut Microbiome in Gynecological Cancer Patients With Pelvic Toxicity: Controls Versus Ozone Treatment. (MicrOzoGineTox)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Bernardino Clavo, MD, PhD","has_results":false},{"nct_id":"NCT06145802","title":"Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors)","phase":"NA","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT06834542","title":"Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT06191900","title":"Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)","phase":"NA","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT06904131","title":"A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Obstetrics & Gynecology Hospital of Fudan University","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}